Chronomedicine

Good drugs fail when timed wrong. We fix that.

Precision circadian analytics for drug rescue and repurposing.

The problem

Dosing against the clock.

Highly effective drugs fail when given at the wrong time

  • Almost no trials take timing into consideration
  • Potentially life-saving drugs fail or are underutilized
  • Need for precision circadian timing, not one-size-fits-all
Chronomedicine page Let's get started (1)
Copy of Chronomedicine page Let's get started (2)
The solution

Circadian science + AI to find mistimed potential.

Our proprietary chronoRCT™ AI identifies drugs that failed due to mistimed dosing—unlocking new therapeutic potential through circadian-informed trial design. Arcasync™, our precision dosing engine, integrates gold-standard biospecimen and wearable data to personalize treatment timing for each patient.

Our process

The future of drug rescue through time and tech.

We combine digital tools and circadian insights to revive failed drugs and unlock new potential.

AI-fueled drug discovery

Our generative PK/PD models, informed by real biological data, identify optimal dosing windows at scale.
Best-in-class noninvasive circadian tracking

Peer-reviewed science supports our ability to predict gold standard biomarkers through ubiquitous consumer devices.
The best time for this drug, for this patient

Precision dosing that seamlessly accounts for real world variability, enhancing effect sizes and improving outcomes.
Who we are

Team

Team of 6 FTEs, including 3 PhDs and recognized leaders in circadian science backed by >$5M in NIH funding.

Olivia Walch

CEO

Eric Canton

CTO

Doug Marttila

Head of Product

Franco Tavella

Lead Research Scientist

Arman Soudi

Technical Lead

Katerina Garcia

Head of Design

Tamara Brady

Marketing Director

Unlocking timing in medicine is a transformative opportunity.

Let's talk about how you can be part of it.